These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33159955)

  • 1. Small interfering RNAs (siRNAs) based gene silencing strategies for the treatment of glaucoma: Recent advancements and future perspectives.
    Naik S; Shreya AB; Raychaudhuri R; Pandey A; Lewis SA; Hazarika M; Bhandary SV; Rao BSS; Mutalik S
    Life Sci; 2021 Jan; 264():118712. PubMed ID: 33159955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress on ocular siRNA gene-silencing therapy and drug delivery systems.
    Jiang J; Zhang X; Tang Y; Li S; Chen J
    Fundam Clin Pharmacol; 2021 Feb; 35(1):4-24. PubMed ID: 32298491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.
    Guzman-Aranguez A; Loma P; Pintor J
    Br J Pharmacol; 2013 Oct; 170(4):730-47. PubMed ID: 23937539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA Therapeutics in Ocular Diseases.
    Moreno-Montañés J; Bleau AM; Martínez T; Vargas B; González MV; Jiménez AI
    Methods Mol Biol; 2021; 2282():417-442. PubMed ID: 33928588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA therapeutics in ophthalmology - translation to clinical trials.
    Gupta A; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
    Exp Eye Res; 2021 Apr; 205():108482. PubMed ID: 33548256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma.
    Alqawlaq S; Huzil JT; Ivanova MV; Foldvari M
    Nanomedicine (Lond); 2012 Jul; 7(7):1067-83. PubMed ID: 22846092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Journey of siRNA: Clinical Developments and Targeted Delivery.
    Nikam RR; Gore KR
    Nucleic Acid Ther; 2018 Aug; 28(4):209-224. PubMed ID: 29584585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery.
    Fernando O; Tagalakis AD; Awwad S; Brocchini S; Khaw PT; Hart SL; Yu-Wai-Man C
    Mol Ther; 2018 Dec; 26(12):2812-2822. PubMed ID: 30301666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic face of RNAi: in vivo challenges.
    Borna H; Imani S; Iman M; Azimzadeh Jamalkandi S
    Expert Opin Biol Ther; 2015 Feb; 15(2):269-85. PubMed ID: 25399911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising approaches of small interfering RNAs (siRNAs) mediated cancer gene therapy.
    Senapati D; Patra BC; Kar A; Chini DS; Ghosh S; Patra S; Bhattacharya M
    Gene; 2019 Nov; 719():144071. PubMed ID: 31454539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencing.
    Chakraborty C
    Curr Drug Targets; 2007 Mar; 8(3):469-82. PubMed ID: 17348839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [SiRNA technology, the gene therapy of the future?].
    Rácz Z; Hamar P
    Orv Hetil; 2008 Jan; 149(4):153-9. PubMed ID: 18201957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siRNA delivery using nanocarriers - an efficient tool for gene silencing.
    Khurana B; Goyal AK; Budhiraja A; Arora D; Vyas SP
    Curr Gene Ther; 2010 Apr; 10(2):139-55. PubMed ID: 20353386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in synthetic siRNA delivery.
    Manjunath N; Dykxhoorn DM
    Discov Med; 2010 May; 9(48):418-30. PubMed ID: 20515610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concepts in in vivo siRNA delivery for cancer therapy.
    Gondi CS; Rao JS
    J Cell Physiol; 2009 Aug; 220(2):285-91. PubMed ID: 19391103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics.
    Akhtari J; Tafazoli A; Mehrad-Majd H; Mahrooz A
    Curr Clin Pharmacol; 2018; 13(3):173-182. PubMed ID: 29992895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene silencing of HIV-1 by RNA interference.
    Takaku H
    Antivir Chem Chemother; 2004 Mar; 15(2):57-65. PubMed ID: 15185724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breaking down the barriers: siRNA delivery and endosome escape.
    Dominska M; Dykxhoorn DM
    J Cell Sci; 2010 Apr; 123(Pt 8):1183-9. PubMed ID: 20356929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.